Patent · US Active

Asymmetric piperidinyl-substituted ureas as medicines

US9546157B2 · kind B2 · utility

3Cited by

1References

38Claims

0Family size

Assignee

Helsinn Healthcare SA · CH

Inventors

Claudio Giuliano · Como, IT
Silvina Garcia Rubio · Princeton, US
Antoine Daina · Lausanne, CH
Angelo Guainazzi · Iselin, US
Claudio Pietra · Como, IT

Key dates

Filing date	Mar 6, 2015
Grant date	Jan 17, 2017
Priority date	—
Expiry date	Mar 6, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the ghrelin receptor. The compounds have the general Formula I:or pharmaceutically acceptable salts thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.